# Safety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 Variants

> **NCT05133050** · NA · NOT_YET_RECRUITING · sponsor: **Xinhua Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 510 (estimated)

## Conditions studied

- Alport Syndrome

## Interventions

- **DRUG:** Ramipril

## Key facts

- **NCT ID:** NCT05133050
- **Lead sponsor:** Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-01-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 510 (ESTIMATED)
- **Last updated:** 2021-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05133050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05133050, "Safety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 Variants". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05133050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*